Showing results (11-20 of 12) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Plos One|May 6, 2021
A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteersGeorge F Wohlford, Leo F Buckley, Dinesh Kadariya, et al.Journal of Cardiovascular Pharmacology|July 26, 2022
Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 - a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein-like Receptor 1- on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial InfarctionBenjamin W Van Tassell, George F Wohlford, Marco Giuseppe Del Buono, et al.Pageof 2